Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Century Therapeutics Inc (NASDAQ: IPSC) was $0.99 for the day, down -7.48% from the previous closing price of $1.07. In other words, the price has decreased by -$7.48 from its previous closing price. On the day, 0.7 million shares were traded. IPSC stock price reached its highest trading level at $1.06 during the session, while it also had its lowest trading level at $0.9831.
Ratios:
Our analysis of IPSC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.39 and its Current Ratio is at 10.39. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 04 ’24 when Farid Adrienne sold 1,033 shares for $1.23 per share. The transaction valued at 1,267 led to the insider holds 135,130 shares of the business.
Carr Douglas sold 283 shares of IPSC for $347 on Nov 04 ’24. The SVP Finance & Operations now owns 317,147 shares after completing the transaction at $1.23 per share. On Nov 04 ’24, another insider, Farid Adrienne, who serves as the Officer of the company, bought 1,033 shares for $1.23 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IPSC now has a Market Capitalization of 84178712 and an Enterprise Value of -59337248. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.29 while its Price-to-Book (P/B) ratio in mrq is 0.43. Its current Enterprise Value per Revenue stands at -22.108 whereas that against EBITDA is 0.503.
Stock Price History:
The Beta on a monthly basis for IPSC is 1.77, which has changed by -0.73024523 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, IPSC has reached a high of $5.51, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -21.69%, while the 200-Day Moving Average is calculated to be -53.99%.
Shares Statistics:
IPSC traded an average of 564.01K shares per day over the past three months and 513600 shares per day over the past ten days. A total of 84.76M shares are outstanding, with a floating share count of 34.81M. Insiders hold about 59.06% of the company’s shares, while institutions hold 31.02% stake in the company. Shares short for IPSC as of 1734048000 were 2707165 with a Short Ratio of 5.47, compared to 1731628800 on 2259285. Therefore, it implies a Short% of Shares Outstanding of 2707165 and a Short% of Float of 3.9.
